Market Insights Health Hospitals Inpatient Care

Treatment of Musculoskeletal Diseases - Iraq

Iraq

In Iraq, the Treatment of Musculoskeletal Diseases market is expected to experience significant growth over the next few years.
By 2024, the projected revenue is estimated to reach US$235.50m.
This growth is expected to continue at an annual growth rate of 2.33% between 2024 and 2029, resulting in a market volume of US$264.20m by 2029.
When compared to other countries globally, United States is projected to generate the highest revenue in this market.
In 2024, the revenue generated United States is expected to amount to US$60,790.00m.
Despite the challenges faced in Iraq, the treatment of musculoskeletal diseases has seen significant advancements in recent years, providing hope for patients in the country.

Key regions: Europe, Canada, United States, Germany, India

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.